Cargando…
Can We Treat Secondary Progressive Multiple Sclerosis Now?
Secondary progressive multiple sclerosis (SPMS) is characterized by progressive accumulation of disability without intermittent recovery. Treatment of these patients is challenging due to limited understanding of pathogenesis and fewer therapeutic options. This article summarizes difficulties in def...
Autores principales: | Bhatia, Rohit, Singh, Nishita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472227/ https://www.ncbi.nlm.nih.gov/pubmed/31007422 http://dx.doi.org/10.4103/aian.AIAN_345_18 |
Ejemplares similares
-
Chronic cerebrospinal venous insufficiency in Multiple Sclerosis: A note for caution
por: Bhatia, Rohit, et al.
Publicado: (2012) -
Where are we now with aphasia after Stroke?
por: Enderby, Pam, et al.
Publicado: (2020) -
Consensus Statement On Immune Modulation in Multiple Sclerosis and Related Disorders During the COVID-19 Pandemic: Expert Group on Behalf of the Indian Academy of Neurology
por: Bhatia, Rohit, et al.
Publicado: (2020) -
Thymectomy in Non-Thymomatous Myasthenia Gravis: Does An RCT Solve The 75-Year-Old Controversy?
por: Singh, Nishita, et al.
Publicado: (2020) -
Secondary Prevention of Rheumatic Heart Disease in Nepal: Are We Going Backward?
por: Regmi, Prakash Raj, et al.
Publicado: (2022)